Merck (NYSE:MRK), one of the biggest drugmakers on the planet, may not be among the most exciting or innovative health care companies, but it is often favored by long-term investors. In this video, health care analyst Max Macaluso dives into three compelling reasons why investors should think about buying Merck.

Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.